Abbott Laboratories stock after-hours at EUR 89.73: plus 3.70 percent versus prior close
Published on 10/05/2026 at 20:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott Laboratories stock was at EUR 89.73 after-hours at 8:34 p.m. CEST on October 5, 2026, according to Lang & Schwarz. The price was up plus 3.70 percent versus the Lang & Schwarz prior close of EUR 86.53.
After-hours trading
The October 5 price indication was separate from Abbott's company announcement. The further course of after-hours trading at Lang & Schwarz until 11:00 p.m. CEST is shown by the continuously updated real-time quote of Abbott Laboratories stock.
FDA approval expands CardioMEMS capabilities
Abbott announced on October 5 that the U.S. Food and Drug Administration approved updates to its CardioMEMS HF System. The changes enable new patient-facing capabilities through the CardioGuide HF App, including allowing U.S. patients to view pulmonary artery pressure readings directly on their smartphones. The company said the capabilities are intended to help patients stay connected with care teams between doctor visits. Abbott said the update also includes Dynamic Treatment Plan, a software feature that lets clinicians create personalized medication adjustment plans based on changes in pulmonary artery pressure.
Abbott plans to make the CardioGuide HF App and Dynamic Treatment Plan available later in 2026, according to the release. The CardioGuide HF App is designed for people with a CardioMEMS pulmonary artery pressure sensor and displays their readings and trends on iOS or Android smartphones. Abbott said the system uses an implanted pulmonary artery pressure sensor, the CardioMEMS HERO device and the Merlin.net Patient Care Network Portal.
